Status:
COMPLETED
The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
Lead Sponsor:
The Camelot Foundation
Conditions:
CoVid 19 Positive
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Diagnostic determination of disease and treatment responses has been limited to qualitative imaging, measurement of serum markers of disease, and sampling of tissue. In each of these instances, there ...
Detailed Description
FMTVDM - See Appendix A. 1. Quantitatively calibrates the nuclear camera to guarantee that the measurements made by the camera are accurate, consistent and reproducible. This quantification is depend...
Eligibility Criteria
Inclusion
- CoVid-19 -
Exclusion
- Decision by patient to not participate.
- \-
Key Trial Info
Start Date :
April 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2020
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT04349410
Start Date
April 11 2020
End Date
September 14 2020
Last Update
November 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FHHI-OI-Camelot; QME
Los Angeles, California, United States, 90245